Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.236
Neutral
RSI(14)
54.853
Neutral
STOCH(KDJ)(9,3,3)
79.354
Buy
ATR(14)
0.558
High Vlolatility
CCI(14)
127.442
Buy
Williams %R
7.606
Overbought
TRIX(12,20)
-0.179
Sell
StochRSI(14)
100.000
Buy
Siriuspoint Ltd
SPNT20.790USD
+0.300+1.46%
Close 02/06, 16:00（ET）Quotes delayed by 15 min
2.43BMarket Cap
12.58P/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of Siriuspoint Ltd
Currency: USD Updated: 2026-02-06Key Insights
Siriuspoint Ltd's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is significant.Its valuation is considered fairly valued, ranking 41 out of 114 in the Insurance industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 23.50.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Siriuspoint Ltd's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Negative
Siriuspoint Ltd Highlights
StrengthsRisks
SiriusPoint Ltd. is a Bermuda-based global underwriter of insurance and reinsurance providing solutions to clients and brokers around the world. The Company has licenses to write property and casualty and accident and health insurance and reinsurance globally. The Company’s segments include Reinsurance and Insurance & Services. In the Reinsurance segment, the Company provides reinsurance products to insurance and reinsurance companies, government entities, and other risk-bearing vehicles on a treaty or facultative basis. The Reinsurance segment predominantly underwrites casualty, property and specialty lines of business on a worldwide basis. For reinsurance assumed, it participates in the reinsurance market with a global focus through the broker market distribution channel. Through the Insurance & Services segment, the Company underwrites primary insurance in a number of sectors. The Insurance & Services segment includes accident and health, casualty, and specialty.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 33.82% year-on-year.
Fairly Valued
The company’s latest PE is 12.58, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 102.34M shares, decreasing 34.07% quarter-over-quarter.
Held by HACAX
Star Investor HACAX holds 221.45K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.71.
Analyst Rating
Based on
3
analysts
Buy
Current Rating
23.500
Target Price
+14.69%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Financial Health
Currency: USD Updated: 2026-02-06The current financial score of Siriuspoint Ltd is 4.07, ranking 109 out of 114 in the Insurance industry. Its financial status is weak, and its operating efficiency is low. Its latest quarterly revenue reached 753.80M, representing a year-over-year increase of 10.82%, while its net profit experienced a year-over-year increase of 1870.45%.
Score
Financials
5.14
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
2.39
Operational Efficiency
3.78
Growth Potential
4.00
Shareholder Returns
5.03
Siriuspoint Ltd's Company Valuation
Currency: USD Updated: 2026-02-06The current valuation score of Siriuspoint Ltd is 6.71, ranking 81 out of 114 in the Insurance industry. Its current P/E ratio is 12.58, which is 202.37% below the recent high of 38.04 and 298.42% above the recent low of -24.97.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 41/114
Relevant data have not been disclosed by the company yet.
Earnings Forecast
Currency: USD Updated: 2026-02-06The current earnings forecast score of Siriuspoint Ltd is 7.33, ranking 38 out of 114 in the Insurance industry. The average price target is 22.50, with a high of 25.00 and a low of 20.00.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Analyst Rating
Based on
3
analysts
Buy
Current Rating
23.500
Target Price
+14.69%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
9
Total
3
Median
6
Average
Company name
Ratings
Analysts
Siriuspoint Ltd
SPNT
3
Renaissancere Holdings Ltd
RNR
18
Everest Group Ltd
EG
17
Reinsurance Group of America Inc
RGA
10
Hamilton Insurance Group Ltd
HG
7
Fundamental Global Inc
FGF
2
1
2
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2026-02-06The current price momentum score of Siriuspoint Ltd is 9.47, ranking 10 out of 114 in the Insurance industry. Currently, the stock price is trading between the resistance level at 21.43 and the support level at 19.65, making it suitable for range-bound swing trading.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
20.440
Buy
MA10
20.260
Buy
MA20
20.139
Buy
MA50
21.041
Sell
MA100
19.858
Buy
MA200
19.406
Buy
Institutional Confidence
Currency: USD Updated: 2026-02-06The current institutional shareholding score of Siriuspoint Ltd is 7.00, ranking 38 out of 114 in the Insurance industry. The latest institutional shareholding proportion is 87.61%, representing a quarter-over-quarter decrease of 6.98%. The largest institutional shareholder is The Vanguard, holding a total of 12.06M shares, representing 10.33% of shares outstanding, with 10.38% increase in holdings.
Score
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Shareholder Activity
Name
Shares Held
Chg %
Loeb (Daniel S)
BlackRock Institutional Trust Company, N.A.
Dimensional Fund Advisors, L.P.
Capital Research Global Investors
American Century Investment Management, Inc.
Victory Capital Management Inc.
Wellington Management Company, LLP
State Street Investment Management (US)
1
2
Risk Assessment
Currency: USD Updated: 2026-02-06The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Insurance domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Siriuspoint Ltd is 8.07, ranking 42 out of 114 in the Insurance industry. The company's beta value is 0.67. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.
Score
Beta vs S&P 500 index
0.67
VaR
+3.21%
240-Day Maximum Drawdown
+16.28%
240-Day Volatility
+33.96%
Return
Best Daily Return
60 days
+3.29%
120 days
+3.74%
5 years
+15.42%
Worst Daily Return
60 days
-4.57%
120 days
-4.62%
5 years
-14.80%
Sharpe Ratio
60 days
+0.90
120 days
+1.03
5 years
+0.59
Risk Assessment
Maximum Drawdown
240 days
+16.28%
3 years
+16.28%
5 years
+62.25%
Return-to-Drawdown Ratio
240 days
+2.82
3 years
+3.86
5 years
+0.32
Skewness
240 days
-0.10
3 years
+0.80
5 years
+0.00
Volatility
Realised Volatility
240 days
+33.96%
5 years
+35.03%
Standardised True Range
240 days
+2.66%
5 years
+1.59%
Downside Risk-Adjusted Return
120 days
+150.67%
240 days
+150.67%
Maximum Daily Upside Volatility
60 days
+18.49%
Maximum Daily Downside Volatility
60 days
+19.02%
Liquidity
Average Turnover Rate
60 days
+0.62%
120 days
+0.64%
5 years
--
Turnover Deviation
20 days
+70.83%
60 days
+42.94%
120 days
+47.60%
Peer Comparison
Insurance
Siriuspoint Ltd
SPNT
6.89 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Essent Group Ltd
ESNT
8.87 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Arch Capital Group Ltd
ACGL
8.84 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Renaissancere Holdings Ltd
RNR
8.63 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
AXIS Capital Holdings Ltd
AXS
8.61 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Everest Group Ltd
EG
8.52 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
